Mylan Executive Targeted in Generic Drug Pricing Probe

The video discusses the Mylan case, where 45 states are investigating alleged collusion among drug makers, targeting a senior executive at Mylan. This case is significant as it involves high-level management, unlike typical cases involving lower-level employees. Parallel federal and state investigations are ongoing, with previous arrests in smaller companies. The generic drug industry faces challenges from increased competition and regulatory pressures, exacerbated by these legal issues. Mylan has yet to respond, but a statement is expected soon.

What impact are the ongoing investigations having on the generic drug industry?

What has been Mylan's response to the allegations and investigations?